InformationResearch & Development
Presentation at the 19th Clinical Trials on Alzheimer's Disease Conference (CTAD)
- #Conference Presentations
Sysmex Corporation will present the latest data on the development of blood-based biomarkers for Alzheimer's disease at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting, to be held in Boston, USA, from November 16-19, 2026.
[Poster presentation]
| Session / Poster No. | Subject | Presenter (Affiliation) |
|---|---|---|
Biomarkers (CSF & Plasma) / P288 | Development and Analytical Validation of a High-Sensitivity Automated Immunoassay for p-tau205 November 18, 7:15 a.m. – 5:30 p.m. (EST) | Masashi Mori (Sysmex corporation) |
- *Information contained in the news is current as of the date of the announcement, but may be subject to change without prior notice.
